Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 3 2Phase 2 1Phase 1 1

Status

Completed 4Withdrawn 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 63INDUSTRY 7OTHER_GOV 3

Study Type

Observational 7Interventional 7

Sponsor

Cancer Type

Classical hematology 2Genitourinary 1Gastrointestinal 1

Conditions

Neoplasms 2875Carcinoma, Non-Small-Cell Lung 2428Breast Neoplasms 2068Colorectal Neoplasms 1247Neoplasm Metastasis 1232Prostatic Neoplasms 1080Melanoma 974Multiple Myeloma 963Ovarian Neoplasms 904Recurrence 852Leukemia, Myeloid, Acute 810Lung Neoplasms 758Pancreatic Neoplasms 753Lymphoma, Non-Hodgkin 727Lymphoma 660Stomach Neoplasms 623Carcinoma, Hepatocellular 566Carcinoma, Renal Cell 546Squamous Cell Carcinoma of Head and Neck 529Leukemia, Lymphocytic, Chronic, B-Cell 493Lymphoma, Follicular 468Head and Neck Neoplasms 451Glioblastoma 436Advanced Solid Tumors 432Small Cell Lung Carcinoma 411Triple Negative Breast Neoplasms 410Lymphoma, Large B-Cell, Diffuse 398Leukemia 394Uterine Cervical Neoplasms 369Advanced Solid Tumor 351

Interventions

maleimide-polyethylene glycol-modified hemoglobin, MP4 1bemiparin 1Uterine Myomectomy 1Ringer's Solution 1Ringer's Lactate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
INDUSTRY × Interventional × Hemorrhage × Clear all
NCT07410117 2026-05-27

ROXI-CAT-I

Regeneron Pharmaceuticals

Phase 3 Recruiting
1,120 enrolled
Classical hematology

Hemorrhage, Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT06456125 2024-06-17

OPAL

LVD Biotech S.L

Phase NA Active not recruiting
70 enrolled

Aneurysm, Hemorrhage, Varicose Veins, Aneurysm, False, Vascular Malformations

NCT01328067 2018-06-15

Study to Evaluate the Safety and Effectiveness of MRgFUS Compared With Myomectomy for the Treatment of Uterine Fibroids

InSightec

Phase NA Withdrawn

Hemorrhage, Leiomyoma, Pelvic Pain

NCT02204930 2015-10-21

PeproStat Haemostat Study in Subjects Undergoing Liver Surgery

Haemostatix Ltd

Phase 1 Completed
20 enrolled
Gastrointestinal

Hemorrhage, Carcinoma, Hepatocellular, Liver Neoplasms

NCT00425334 2013-08-19

Safety Study of HemospanĀ® in Prostatectomy Patients

Sangart

Phase 2 Completed
20 enrolled
Genitourinary

Hemorrhage, Ischemia, Prostatic Neoplasms, Blood Loss, Surgical

NCT01092988 2012-02-22

A Clinical Study to Evaluate Safety of the ExAblate 2100 UF V2 System in the Treatment of Symptomatic Uterine Fibroids

InSightec

Phase NA Completed
40 enrolled

Hemorrhage, Leiomyoma, Pain

NCT00219973 2010-04-28

CANBESURE STUDY (Cancer, Bemiparin and Surgery Evaluation)

Rovi Pharmaceuticals Laboratories

Phase 3 Completed
526 enrolled
Classical hematology

Hemorrhage, Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚔